Drug Interactions between Cabenuva and Voxzogo
This report displays the potential drug interactions for the following 2 drugs:
- Cabenuva (cabotegravir/rilpivirine)
- Voxzogo (vosoritide)
Interactions between your drugs
No interactions were found between Cabenuva and Voxzogo. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Cabenuva
A total of 460 drugs are known to interact with Cabenuva.
- Cabenuva is in the drug class antiviral combinations.
- Cabenuva is used to treat HIV Infection.
Voxzogo
A total of 122 drugs are known to interact with Voxzogo.
- Voxzogo is in the drug class miscellaneous hormones.
- Voxzogo is used to treat Achondroplasia.
Drug and food/lifestyle interactions
rilpivirine food/lifestyle
Applies to: Cabenuva (cabotegravir / rilpivirine)
Food significantly increases the absorption of rilpivirine. You should take each dose of rilpivirine with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication. Grapefruit juice can also increase the absorption of rilpivirine and should preferably be avoided.
vosoritide food/lifestyle
Applies to: Voxzogo (vosoritide)
Vosoritide may cause transient decreases in blood pressure. To reduce the risk of low blood pressure and its associated symptoms, you should have adequate food intake before vosoritide administration and should drink approximately 8 to 10 ounces of liquids within the hour prior to vosoritide injection. Tell your doctor if you experience fatigue, nausea, dizziness, or lightheadedness after vosoritide injection. Avoid driving or operating hazardous machinery until you know how this medication affects you and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.